M+QuickMedCalc
Educational reference only. Not a diagnostic tool. See full disclaimer.
Gastroenterology & HepatologyAST/ALT Ratio

De Ritis Ratio (AST/ALT) Calculator

Calculate the unitless AST-to-ALT ratio from a same-panel pair reported in U/L, with laboratory and non-diagnostic limitations.

Content updated: View sources

QuickMedCalc is developed and maintained by an independent developer. Medical content is not independently reviewed by a physician.

Formula and medical content are based on the references listed on this page. See sources, About, and Sources and Review Process.

Use one contemporaneous laboratory panel with both enzyme activities reported in U/L.

Copy AST from the selected same-panel report. Use ordinary decimal digits only.

Copy ALT from the same report. ALT must be greater than zero because it is the denominator.

Input limits are technical validation and display limits, not healthy, normal, or clinical reference ranges. Scientific notation, signs, embedded units, commas, partial text, and surrounding spaces are rejected.

About

The De Ritis ratio is measured serum aspartate aminotransferase (AST) activity divided by measured alanine aminotransferase (ALT) activity from the same laboratory panel. AST and ALT are enzymes released with cell injury, not direct measures of liver synthetic function. ALT is more concentrated in liver, while AST also occurs in skeletal muscle, heart, and other tissues. [1, 2, 7]

This page reproduces one unitless ratio only. It does not diagnose alcohol-associated liver disease, viral hepatitis, steatotic liver disease, cirrhosis, muscle injury, or another cause; stage fibrosis; estimate prognosis; or choose tests, referral, medication, dose, or treatment. [3, 4, 5, 6]

Formula

De Ritis ratio = AST activity (U/L) ÷ ALT activity (U/L). [1, 2]
AST and ALT must come from the same panel and be expressed in the same unit. This page accepts a matched U/L pair and does not convert or combine incompatible reports. [3, 4]
The ratio is unitless because the same activity unit cancels. ALT must be greater than zero; AST may be zero, yielding a true ratio of 0. [2, 9]
Absolute values remain essential: 40 ÷ 20 and 400 ÷ 200 both equal 2.00, but they do not describe the same biochemical magnitude or clinical setting. [3, 7, 10]

Interpretation

What the result represents

The result describes the relative activity of AST to ALT in one matched serum panel. It cannot show whether either enzyme is above that laboratory's reference interval, how much it changed over time, where AST originated, or whether liver synthetic function is impaired. [3, 7]

Input units and timing

Enter both enzyme activities in U/L from the same specimen or contemporaneous laboratory panel. Do not combine an AST from one date with an ALT from another, or values produced in incompatible units or methods. Review each absolute value against the interval printed by the reporting laboratory. [3, 4, 10]

Worked example

AST 40 U/L and ALT 20 U/L give 40 ÷ 20 = 2.00. The arithmetic does not establish why the relationship occurred and does not label either enzyme normal or abnormal. [2, 3]

Static historical and current context

Static AST-to-ALT ratio interpretation context
Evidence contextSafe interpretation boundary
Original 1957 reportThe ratio was described in acute viral hepatitis before modern serology and molecular testing. It is not a contemporary viral-hepatitis diagnostic test. [1, 3]
Ratio above 2AST/ALT >2 is a commonly discussed clue in alcohol-associated liver disease. Current ACG probable alcohol-associated hepatitis criteria use AST/ALT >1.5 as one component alongside heavy alcohol use >50 g/day for at least 6 months, jaundice onset within 60 days, bilirubin >3 mg/dL, AST 50–400 U/L, and no other cause of acute hepatitis. Neither ratio alone establishes alcohol exposure or a diagnosis. [2, 5, 11]
AST greater than ALTCan accompany cirrhosis from more than one cause, muscle injury, exercise, hemolysis, cardiac injury, or changing illness timing. It is not a disease-specific category. [6, 7, 8]
Ratio below 1Appears in several biochemical patterns but does not confirm viral, metabolic, or another liver disease and does not exclude advanced disease. [1, 3, 6]

The table is fixed evidence context. The calculator never compares, highlights, or classifies a submitted ratio. [2, 11]

Applicable population

The arithmetic can be reproduced when a matched AST and ALT pair is available, but interpretation remains population-, method-, age-, pregnancy-, and context-specific. Pediatric, pregnancy, transplant, acute liver failure, and known muscle-disease assessments require their applicable clinical and laboratory pathways. [3, 4, 5, 6]

Interpretation limitations

There is no universal healthy De Ritis range. A ratio can change because the numerator, denominator, or both changed, and a low ALT can make the quotient large even when AST is not markedly elevated. Laboratory method, pyridoxal-phosphate supplementation, reference intervals, specimen quality, hemolysis, recent strenuous exercise, skeletal-muscle injury, medicines, supplements, cardiac injury, and timing can alter one or both values. Use the absolute AST and ALT, their trends, other liver chemistries, history, examination, and indicated testing rather than this quotient alone. [3, 7, 8, 9, 10]

References

  1. De Ritis F, Coltorti M, Giusti G. An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities. Clin Chim Acta. 1957;2(1):70–74. PMID 13447217. DOI 10.1016/0009-8981(57)90027-X.
  2. Botros M, Sikaris KA. The De Ritis ratio: the test of time. Clin Biochem Rev. 2013;34(3):117–130. PMID 24353357. PMCID PMC3866949.
  3. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18–35. PMID 27995906. DOI 10.1038/ajg.2016.517.
  4. Newsome PN, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6–19. PMID 29122851. PMCID PMC5754852. DOI 10.1136/gutjnl-2017-314924.
  5. Crabb DW, et al. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the AASLD. Hepatology. 2020;71(1):306–333. PMID 31314133. DOI 10.1002/hep.30866.
  6. Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797–1835. PMID 36727674. PMCID PMC10735173. DOI 10.1097/HEP.0000000000000323.
  7. American Association for the Study of Liver Diseases. How to approach elevated liver enzymes. Liver Fellow Network. Updated January 17, 2025.
  8. Pettersson J, et al. Muscular exercise can cause highly pathological liver function tests in healthy men. Br J Clin Pharmacol. 2008;65(2):253–259. PMID 17764474. PMCID PMC2291230. DOI 10.1111/j.1365-2125.2007.03001.x.
  9. Schumann G, et al. IFCC reference procedures for measurement of catalytic concentrations of enzymes: corrigendum, notes and useful advice. Clin Chem Lab Med. 2010;48(5):615–621. PMID 20298135. DOI 10.1515/CCLM.2010.137.
  10. Ceriotti F, et al. Common reference intervals for AST, ALT and GGT in serum: results from an IFCC multicenter study. Clin Chem Lab Med. 2010;48(11):1593–1601. PMID 21034260. DOI 10.1515/CCLM.2010.315.
  11. Jophlin LL, et al. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024;119(1):30–54. PMID 38174913. PMCID PMC11040545. DOI 10.14309/ajg.0000000000002572.

FAQ

Related Calculators

Disclaimer

Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.